Decipher Labs
DECIPHERLABSLTD NSE
Decipher Labs
HealthcareNSE: DECIPHERLABSLTD BSE: DECIPHER Pharmaceuticals
Key Fundamentals
MicrocapPharmaceuticalsHealthcareMarket Cap
₹5.80 Cr
Volatility
Moderate
P/E Ratio
-1.9
EBITDA
₹-3.39 Cr
Return on Equity
-22.23%
Debt to Equity
0.02
Book Value
₹20.47
EPS
₹0
52W High
₹11.2
52W Low
₹5
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company is almost debt free.
- Stock is trading at 0.29 times its book value
Weaknesses
5- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -24.0% over past five years.
- Promoter holding is low: 16.4%
- Company has a low return on equity of -6.51% over last 3 years.
- Working capital days have increased from 226 days to 395 days
Growth Rate
Revenue Growth
-41.21% lower than
3Y
Net Income Growth
-27.84% lower than
3Y
Cash Flow Change
-302% higher than
3Y
ROE
190% higher than
3Y
ROCE
515% higher than
3Y
EBITDA Margin (Avg.)
-3.81%
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.51 | 7.49 | 8.29 | 10.59 | 7.44 | 5.87 | 5.8 | 3.5 | 2.92 | 4.31 | 3.21 | 3.6 | 2.41 |
| Expenses | 9.65 | 9.66 | 8.16 | 9.38 | 6.13 | 7.2 | 6.43 | 10.08 | 6.24 | 4.19 | 3.64 | 3.37 | 4.57 |
| Operating Profit | -0.14 | -2.17 | 0.13 | 1.21 | 1.31 | -1.33 | -0.63 | -6.58 | -3.32 | 0.12 | -0.43 | 0.23 | -2.16 |
| OPM % | -1.47% | -28.97% | 1.57% | 11.43% | 17.61% | -22.66% | -10.86% | -188% | -113.7% | 2.78% | -13.4% | 6.39% | -89.63% |
| Other Income | 0.01 | 0.14 | 0 | 0.27 | 0.16 | 0.12 | 0.17 | 0.87 | 0.01 | 0.02 | 0.02 | 0.17 | 0.1 |
| Interest | 0.01 | 0 | 0 | 0.21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.11 | 0.11 | 0.12 | 0.11 | 0.11 | 0.12 | 0.12 | 0.13 | 0.12 | 0.13 | 0.13 | 0.15 | 0.13 |
| PBT | -0.25 | -2.14 | 0.01 | 1.16 | 1.36 | -1.33 | -0.58 | -5.84 | -3.43 | 0.01 | -0.54 | 0.25 | -2.19 |
| Tax % | 280% | -9.35% | 0% | -3.45% | 30.15% | 0% | 1.72% | -29.62% | 0% | 0% | 1.85% | 244% | 0% |
| Net Profit | -0.95 | -1.94 | 0.01 | 1.2 | 0.95 | -1.33 | -0.59 | -4.11 | -3.43 | 0.02 | -0.54 | -0.36 | -2.19 |
| EPS in Rs | -0.94 | -1.92 | 0.01 | 1.19 | 0.94 | -1.32 | -0.58 | -4.07 | -3.4 | 0.02 | -0.53 | -0.36 | -2.17 |
Profit & Loss
| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.02 | 8.06 | 23.99 | 55.56 | 65.32 | 45.57 | 35.88 | 22.61 | 14.05 | 13.53 |
| Expenses | 0.95 | 7.61 | 21.47 | 52.08 | 59.29 | 49.74 | 36.56 | 24.5 | 17.44 | 15.77 |
| Operating Profit | 0.07 | 0.45 | 2.52 | 3.48 | 6.03 | -4.17 | -0.68 | -1.89 | -3.39 | -2.24 |
| OPM % | 6.86% | 5.58% | 10.5% | 6.26% | 9.23% | -9.15% | -1.9% | -8.36% | -24.13% | -16.56% |
| Other Income | 0.11 | 0 | 0.27 | 0.65 | 7.67 | 0.92 | 0.16 | -4.02 | 0.22 | 0.31 |
| Interest | 0 | 0.01 | 0.77 | 1.17 | 0.48 | 0.48 | 0.24 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0.56 | 0.82 | 0.87 | 0.43 | 0.45 | 0.48 | 0.52 | 0.54 |
| PBT | 0.18 | 0.44 | 1.46 | 2.14 | 12.35 | -4.16 | -1.21 | -6.39 | -3.69 | -2.47 |
| Tax % | 0% | 9.09% | 25.34% | 34.58% | 7.85% | -35.58% | 38.02% | -20.5% | -16.26% | — |
| Net Profit | 0.18 | 0.41 | 1.1 | 1.4 | 11.38 | -2.68 | -1.68 | -5.08 | -3.08 | -3.07 |
| EPS in Rs | 0.22 | 0.51 | 1.09 | 1.39 | 11.27 | -2.65 | -1.66 | -5.03 | -3.05 | -3.04 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 10.1 | 10.1 | 10.1 | 10.1 | 10.1 | 10.1 | 10.1 |
| Reserves | -5.88 | -5.47 | 2.46 | 3.59 | 14.07 | 13.11 | 11.76 | 12.76 | 10.57 |
| Borrowings | 0.13 | 0.2 | 11.28 | 16.39 | 10.32 | 0.95 | 0 | 0.24 | 0.5 |
| Other Liabilities | 0.71 | 3.61 | 11.55 | 8.64 | 7.46 | 4.01 | 11.77 | 2.66 | 3.16 |
| Total Liabilities | 2.96 | 6.34 | 35.39 | 38.72 | 41.95 | 28.17 | 33.63 | 25.76 | 24.33 |
| Fixed Assets | 0 | 0.01 | 4.98 | 4.43 | 2.83 | 3.31 | 2.91 | 2.54 | 2.53 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0.26 | 3.76 | 3.39 | 0.26 | 0 |
| Other Assets | 2.96 | 6.33 | 30.41 | 34.29 | 38.86 | 21.1 | 27.33 | 22.96 | 21.8 |
| Total Assets | 2.96 | 6.34 | 35.39 | 38.72 | 41.95 | 28.17 | 33.63 | 25.76 | 24.33 |
Cash Flow
| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Operating | -0.1 | 0.23 | -15.18 | 1.83 | 8.26 | -1.56 | 4.85 | -9.82 | -2.08 |
| Investing | 0 | -0.02 | -0.01 | -0.31 | -1.13 | -4.28 | -1.79 | 3.07 | -0.24 |
| Financing | 0.09 | 0.07 | 16.36 | 3.99 | 1.3 | -2.15 | -1.17 | 0.24 | 0.26 |
| Net Cash Flow | -0.01 | 0.28 | 1.17 | 5.51 | 8.43 | -7.99 | 1.9 | -6.51 | -2.07 |
| Free Cash Flow | -0.1 | 0.22 | -15.42 | 1.52 | 8.06 | -2.34 | 4.79 | -9.88 | -2.32 |
| CFO/OP | -143 | 51 | -602 | 53 | 137 | 37 | -713 | 520 | 61 |
Ratios
| Particulars | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 211 | 157 | 222 | 76.67 | 71.47 | 78.9 | 79.35 | 68.12 | 67.54 |
| Inventory Days | 91.25 | 19.7 | — | — | — | — | 0 | — | — |
| Days Payable | 511 | 193 | — | — | — | — | — | — | — |
| Cash Conversion Cycle | -209 | -16.27 | 222 | 76.67 | 71.47 | 78.9 | 79.35 | 68.12 | 67.54 |
| Working Capital Days | 751 | 99.63 | -2.13 | -11.5 | 65.43 | 61.67 | 36.52 | 247 | 395 |
| ROCE % | — | 18.07% | 16.79% | 12.28% | 39.74% | 9.45% | -3.09% | -4.67% | -16.67% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Decipher Labs insights
56 extracted metrics + investor summaries across FY12–FY26.
Documents
1
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
22 Apr - Decipher Labs reports it is not a Large Corporate; FY26 borrowing nil. 22 Apr - Decipher Labs reports it is not a Large Corporate; FY26 borrowing nil.
2
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
13h - Decipher Labs reports it is not a Large Corporate; FY26 borrowing nil. 13h - Decipher Labs reports it is not a Large Corporate; FY26 borrowing nil.
3
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
21 Apr - Company says it is not a Large Corporate; FY2026-27 initial disclosure not applicable, borrowing Rs. 50,47,590. 21 Apr - Company says it is not a Large Corporate; FY2026-27 initial disclosure not applicable, borrowing Rs. 50,47,590.
4
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
13h - Company says it is not a Large Corporate; FY2026-27 initial disclosure not applicable, borrowing Rs. 50,47,590. 13h - Company says it is not a Large Corporate; FY2026-27 initial disclosure not applicable, borrowing Rs. 50,47,590.
5
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
17 Apr - Compliance as per Regulation 74 (5) of SEBI (Depositories And Participants) Regulation ,2018 for the quarter ended 31st March 2026 17 Apr - Compliance as per Regulation 74 (5) of SEBI (Depositories And Participants) Regulation ,2018 for the quarter ended 31st March 2026
Frequently Asked Questions about Decipher Labs
What does Decipher Labs Ltd do?
Incorporated in 1986, Decipher Labs Ltd deals in pharma and consultancy business.[1]
Where is Decipher Labs Ltd (524752) listed?
Decipher Labs Ltd trades as DECIPHERLABSLTD on the NSE and under code DECIPHER on the BSE.
Which sector does Decipher Labs Ltd belong to?
Decipher Labs Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Decipher Labs Ltd?
Decipher Labs Ltd has a market capitalisation of ₹5.8 Cr, which places it in the Small Cap band.
What is the PE ratio of Decipher Labs Ltd?
Decipher Labs Ltd trades at a PE ratio of -1.90, on earnings per share of ₹0, against a book value of ₹20.47 per share.
What is the 52-week high and low of Decipher Labs Ltd?
Over the last 52 weeks Decipher Labs Ltd has traded between ₹5 and ₹11.2.
What is the Return on Equity (ROE) of Decipher Labs Ltd?
Decipher Labs Ltd reported a return on equity of -22.23%. Its debt-to-equity ratio is 0.02.
Company Information
Incorporated in 1986, Decipher Labs Ltd deals in pharma and consultancy business.[1]
Website combatdrugs.in
Face Value ₹ 10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524752.md for Decipher Labs Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.